Skip to main content

19-09-2020 | ESMO 2020 | Conference coverage | Video

JAVELIN Bladder 100: Identifying biomarkers for maintenance avelumab


Thomas Powles discusses the key findings from the biomarker analyses of the JAVELIN Bladder 100 study of maintenance avelumab in patients with advanced urothelial cancer (3:56).

This independent video interview was supported by an educational grant from Pfizer and Merck Healthcare KGaA, Darmstadt, Germany

Read transcript

New additions to the Adis Journal Club

A selection of topical peer-reviewed articles from the Adis journals, curated by the editors.

ESMO 2022 congress coverage

Access the latest news and expert insight from the 2022 European Society for Medical Oncology Congress